| Serial Number | 90182575 |
| Word Mark | PIRLIFDI |
| Filing Date | Tuesday, September 15, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, December 16, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 14, 2021 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for use in disease testing |
| Translation of Words in Mark | The word(s) "PIRLIFDI" has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 22, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08543 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Friday, September 18, 2020 | NEW APPLICATION ENTERED |
| Thursday, October 22, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 27, 2021 | ASSIGNED TO EXAMINER |
| Friday, January 29, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, January 29, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, January 29, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, July 27, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 27, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 28, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 5, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, August 5, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 5, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 5, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, August 5, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, August 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, August 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, August 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 14, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 9, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, May 5, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 5, 2022 | SOU EXTENSION 1 FILED |
| Thursday, May 5, 2022 | SOU EXTENSION 1 GRANTED |
| Saturday, May 7, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, November 2, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, November 2, 2022 | SOU EXTENSION 2 FILED |
| Wednesday, November 2, 2022 | SOU EXTENSION 2 GRANTED |
| Friday, November 4, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, April 26, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, April 26, 2023 | SOU EXTENSION 3 FILED |
| Wednesday, April 26, 2023 | SOU EXTENSION 3 GRANTED |
| Friday, April 28, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, August 2, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, October 12, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 12, 2023 | SOU EXTENSION 4 FILED |
| Thursday, October 12, 2023 | SOU EXTENSION 4 GRANTED |
| Saturday, October 14, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 5, 2024 | SOU EXTENSION 5 FILED |
| Friday, April 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 5, 2024 | SOU EXTENSION 5 GRANTED |
| Saturday, April 6, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, December 16, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, December 16, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |